ATAI Life Sciences NV (9VC) — Long-term Investment Intensity
ATAI Life Sciences NV (9VC) has a Long-term Investment Intensity of 36.8% as of September 2025. Long-term investments of €88.36 Million represent 36.8% of total assets of €239.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ATAI Life Sciences NV (9VC) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ATAI Life Sciences NV Long-term Investment Intensity (2019–2024)
This chart shows how ATAI Life Sciences NV's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 36.8%, reflecting long-term investments of €88.36 Million against total assets of €239.82 Million EUR. Also explore 9VC total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for ATAI Life Sciences NV (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for ATAI Life Sciences NV from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ATAI Life Sciences NV (9VC) market capitalisation.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 44.5% | €70.97 Million | €159.39 Million | ▲ +13.3 pp |
| 2023 | 31.2% | €91.66 Million | €293.48 Million | ▲ +29.0 pp |
| 2022 | 2.2% | €6.75 Million | €305.44 Million | ▼ -4.5 pp |
| 2021 | 6.7% | €27.76 Million | €414.17 Million | ▼ -0.5 pp |
| 2020 | 7.2% | €8.04 Million | €111.55 Million | ▼ -29.7 pp |
| 2019 | 36.9% | €22.95 Million | €62.12 Million | — |